National Public Health Institute, Department of Mental Health and Alcohol Research, Helsinki, Finland
Correspondence: Annamari Tuulio-Henriksson, National Public Health Institute, Department of Mental Health and Alcohol Research, Mannerheimintie 166, 00300 Helsinki, Finland. Tel: +358 9 4744 8548; fax: +358 9 4744 8478; e-mail: annamari.tuulio-henriksson{at}ktl.fi
Declaration of interest Partial financial support received from Millennium Pharmaceuticals Inc. and American Home Products Corp., Wyeth-Ayerst Research Division.
|
|
|---|
Aims To examine the effect of age at onset on cognitive functioning using the California Verbal Learning Test, sub-tests from the Wechsler Memory Scale Revised and sub-scales from the Wechsler Adult Intelligence Scale Revised among families with schizophrenia.
Method The effect of age at onset on cognitive function in 237 people with schizophrenia from a population-based sample was examined using linear mixed effects models with family as the random effect, and age, gender, chronicity of the illness and number of affected first-degree relatives as fixed effects.
Results Impairment in verbal learning and memory was associated with earlier disease onset. No association was found for working memory or IQ.
Conclusions In patients with early-onset schizophrenia, verbal memory functions in particular should be taken into account in neuropsychological evaluation and efforts at remediation.
|
|
|---|
|
|
|---|
Blood samples were drawn from 930 families identified from the registers; they comprised 281 families originating from a genetic isolate in the north-eastern part of Finland, with at least one child with schizophrenia, schizoaffective psychosis or schizophreniform disorder, and 649 families with at least two children with these disorders from the whole country. The collection of blood samples for the molecular genetic studies (Hovatta et al, 1997; Ekelund et al, 2001; Paunio et al, 2001) followed the recommendations given in the Declaration of Helsinki and its amendments. Consent for drawing the blood sample and for a future contact was documented in writing.
All available psychiatric case notes covering the patients whole illness history were collected for individuals with a diagnosis of schizophrenia, schizoaffective psychosis or schizophreniform disorder in any of the three national registers, and from whom a blood sample was drawn (n=1410). For each case, two psychiatrists, masked to family structure and register diagnosis, assessed independently the best-estimate lifetime diagnoses according to DSMIV criteria (American Psychiatric Association, 1994). One of the assessors also filled out the Operational Criteria Checklist for Psychotic Illness (OPCRIT; McGuffin et al, 1991). Disagreements on the assessment of research diagnoses were reviewed by a third assessor and a consensus was reached.
All 281 families originating from the genetic isolate, and a sample of 50 families from the whole of Finland randomly selected from families who had previously given blood samples, were asked to participate in this study for detailed diagnostic information and neuropsychological examination. We began by contacting affected individuals (with the permission of their treating physician) to begin the informed consent process. After the affected person had given written consent, the rest of the family were contacted and their consent requested, following a complete description of the study.
From the 275 families who gave consent, 411 patients and 561 family members were interviewed using the structured Clinical Interview for DSMIV (SCID; First et al, 1997). All the interviewers received standardised training in the use of this instrument. The final consensus diagnoses were based on data collected from the records, the OPCRIT assessment and the SCID. The same neuropsychological test battery was administered to both affected and unaffected participants. For each family we endeavoured to interview the same number of affected and unaffected siblings, selecting those closest to the probands age and of the same gender, if possible.
We excluded 41 patients who had a diagnosis of a schizophrenia-spectrum disorder in the registers but who were assigned a consensus diagnosis of bipolar disorder, and 11 patients who received a consensus diagnosis of a non-psychotic disorder. Furthermore, we excluded 52 patients with schizoaffective disorder and 20 patients with schizophreniform disorder. This left us with 287 patients with schizophrenia. Of these, 35 either did not give a valid test performance or were untestable because of acute psychotic state or severe medical comorbidity. Reliable information about age at illness onset was not received for 11 patients, and 4 were excluded because of the very early age at onset (712 years). The cut-off point of age > 12 years was chosen on the basis of previous research into childhood-onset schizophrenia (for a review, see Nicolson & Rapoport, 1999).
Our study thus comprised 237 persons with a diagnosis of schizophrenia from 208 families. Of the patients, 81 were women and 156 were men (P<0.001), reflecting a slight overrepresentation of males (66% v. 58% in the registers). The mean ages of women and men were similar, at about 45 years (Table 1). The course of the illness was chronic in 71% of women and 74% of men (data derived from the OPCRIT).
|
View this table: [in a new window] | Table 1 Demographic characteristics of the participants with schizophrenia (n=237) |
Information about the age at onset of schizophrenic illness was derived from the case notes as one of the OPCRIT items. The case notes were comprehensive and covered the in-patient and out-patient phases of the whole treatment history. The age at onset was defined as the earliest age at which medical advice was sought for occurrence of psychiatric symptoms, or at which the symptoms began to cause subjective distress or impair functioning. The mean age at onset in the final sample was 23.2 years with no difference between women and men (Table 1), which is in line with a previous epidemiological study in Finland (Suvisaari et al, 1998). The IQ was estimated from four sub-scales from the Wechsler Adult Intelligence Scale Revised (WAISR; Wechsler, 1981).
Neuropsychological tests
The neuropsychological tests were administered to all participants in a
fixed order. All examiners were psychologists or advanced psychiatric nurses
extensively trained and supervised with the test battery. Experienced
psychologists scored all the tests using the scoring rules detailed in the
test manuals.
The test procedures have been described in detail by Tuulio-Henriksson et al (2002). Auditory attention was assessed with the Digit Span Forward task, and verbal working memory with the Digit Span Backward task of the Wechsler Memory Scale Revised (WMSR; Wechsler, 1987). According to Finnish normative data, the testretest reliability coefficients of the Digit Span sub-tests vary with age from 0.74 to 0.82 (Wechsler, 1996). The Visual Span Forward sub-test of the WMSR (Wechsler, 1987) was used to assess visual attention and the Backward condition of the span task was used to measure visuospatial working memory. According to Finnish normative data, the testretest reliability coefficients of the Visual Span sub-tests vary with age from 0.72 to 0.80 (Wechsler, 1996).
Verbal learning and memory were assessed with the California Verbal Learning Test (CVLT; Delis et al, 1987), which examines recall and recognition of word lists over a number of trials. We report the following variables derived from the test: total recall (learning and memory), semantic clustering, learning from the beginning of the list (primacy) and from the end (recency), recall errors (perseverations and intrusions) and recognition memory (discriminability). No reliability data for Finnish subjects exist, but the split-half reliability of the CVLT is 0.770.86, according to the test manual (Delis et al, 1987).
Four sub-tests of the WAISR were used for measuring IQ. Verbal ability and abstraction were measured with the Vocabulary and Similarities sub-tests, respectively; the vocabulary test is considered to be the best single measure of general ability (Lezak, 1995). The Block Design and Digit Symbol sub-tests have a motor component, as the trials are timed; the former is a measure of visuospatial reasoning, and the latter measures psychomotor speed. According to Finnish normative data, the testretest reliabilities for the Vocabulary, Similarities, Block Design and Digit Symbol measures are 0.890.95, 0.690.88, 0.780.83 and 0.820.86, respectively, depending on age (Wechsler, 1992).
Statistical analyses
The analyses were made using linear mixed effect models separately for each
neuropsychological test variable. Age at onset was treated in the models as a
continuous variable, ranging from 13 to 44 years. In each model, family was
included as a random effect, as from some families more than one family member
was included. Age, gender, course of the illness (chronic v.
episodic) and age at onset (years) were included as the fixed effects.
Furthermore, we included in the models a continuous variable of the number of
affected members in the family as a fixed effect in order to detect whether
familial loading, measured by the number of first-degree relatives with a
psychotic disorder, modifies the effect of the age at onset on cognitive
functions. The information concerning the illness of the first-degree
relatives was obtained from the national registers. In addition, we remodelled
all test variables with the above-mentioned random and fixed effects plus
duration of the illness (tertiles from age at onset subtracted from the age at
testing, in years). All analyses were two-tailed, and the probability level of
P<0.05 indicated statistical significance. Analyses were performed
using the S-Plus statistical software, version 3.4
(S-Plus, 1996).
|
|
|---|
|
View this table: [in a new window] | Table 2 Neuropsychological test results and effect of age at onset of schizophrenia |
Fixed-effect contributions
Course of the illness (chronic v. episodic) contributed to the
measured four IQ functions (all P values <0.03). Chronicity also
showed a significant effect on verbal learning and memory (effect coefficient
-6.245, s.d.=1.8, P<0.001), semantic clustering (effect
coefficient -0.287, s.d.=0.11, P=0.02), delayed verbal memory (effect
coefficient -1.723, s.d.=0.48, P<0.001), recognition memory
(effect coefficient -5.300, s.d.=1.62, P=0.002) and intrusions
(effect coefficient 0.348, s.d.=0.14, P<0.02), but it did not
eliminate the effect of age at onset on these variables. Including duration of
the illness in the models did not change the results, and this variable did
not contribute significantly to any of the measured cognitive functions. The
number of affected first-degree relatives in the family showed a significant
effect on visual working memory (effect coefficient -0.27, s.d.=0.13,
P=0.04), verbal ability (effect coefficient -1.80, s.d.=0.83,
P=0.04) and processing speed (effect coefficient -1.31, s.d.=0.61,
P=0.03).
|
|
|---|
Familial loading, measured as the number of affected first-degree relatives in the family, did not contribute to the effect of age at onset on cognitive functioning, but showed a significant effect on visual working memory, verbal IQ and processing speed. Chronicity contributed strongly to the cognitive test scores, but did not eliminate the significant effect of age at onset from the verbal learning and memory functions.
Strengths and limitations of the study
To our knowledge, this study is the first to examine how the age at onset
is associated with cognitive function, using a large population-based sample
of families of people with schizophrenia. Furthermore, we controlled for the
impact of familial loading. This study design allowed us to take into account
intrafamilial features in the neuropsychological test data. Our analyses
showed that scores in visual working memory and verbal IQ were worse when
there were more affected first-degree relatives in the family, irrespective of
the age at onset. This result provides further support for the evidence of
genetic influence on visual working memory deficits in families with
individuals with schizophrenia that has been reported in previous studies
(Park et al, 1995;
Cannon et al, 2000;
Tuulio-Henriksson et al,
2002).
Since the participants with schizophrenia in our study sample had a wide range of age, some of the results might reflect normal deterioration of cognitive function with increasing age. However, we controlled for the effect of age in the analysis. Moreover, these participants were not people experiencing a first episode, but individuals with an often chronic course of illness who might have been exposed to noxious effects of the illness or medication, with negative effects on cognitive functions. However, by controlling for chronicity, and in additional models also for the duration of the illness in the analysis, we took at least partial account on these potential confounds. Besides, duration of the illness may not be associated with the severity of cognitive deficits in schizophrenia (Heaton et al, 2001).
Our definition of familiality was based on the number of affected first-degree relatives with a psychotic disorder, instead of using the more sophisticated calculations presented by Verdoux et al (1996) or Lawrie et al (2001). However, since the majority of the families under study had at least two affected family members, and therefore represented familial schizophrenia, we considered that it was adequate to use the number of affected family members as a measure of familial loading in the analyses. Furthermore, the method introduced by Lawrie et al (2001) would have assumed spousal correlation to be 0, but this was not always the case in the genetic isolate included in our study sample.
Verbal memory as a vulnerable cognitive function in early-onset schizophrenia
More severe learning and memory impairments, as measured by the total
recall score on the CVLT, have been associated with earlier onset of
schizophrenia (Jeste et al,
1998). In accordance with the study by Jeste et al
(1998), cognitive functions
related to verbal learning and memory, particularly to initial encoding,
showed the strongest associations of interest in our study. This does not
imply a relative impairment of verbal learning and memory compared with the
other measured cognitive functions. However, the association between age at
disease onset and verbal learning and memory remained even in the presence of
chronicity, which accounted for most of the variance of the other cognitive
functions. Turetsky et al
(2002) identified three
memory-delineated subtypes of schizophrenia: based on verbal memory impairment
(measured using the CVLT) these subtypes were defined as those conforming to
the phenotypes of cortical and subcortical dementia, and those with no
impairment. Patients in the group in which the memory deficits (poor total
recall scores on the CVLT and frequent intrusive errors) were similar to those
observed in cortical dementia had an earlier onset of disease than the
unimpaired group (Turetsky et al,
2002). Our results support these findings.
Furthermore, patients with prodromal signs of schizophrenia have been found to show compromised verbal memory (free recall of a word list) measured with the Auditory Verbal Learning Test, which is similar to the CVLT used in our study (Hambrecht et al, 2002). Verbal learning and memory functions may be particularly vulnerable to the developmental process leading to schizophrenia. The poor psychosocial outcome associated with early onset of schizophrenia (Schultz et al, 2000) may be influenced by impairment in the verbal learning and memory functions in particular. The deficits associated with verbal memory functions, inevitably undermining social adaptation and educational possibilities, may predispose individuals to an earlier onset of schizophrenia.
IQ and age at onset
In line with the prospective study by Fuller et al
(2002), we found no
association between age at onset and measures of IQ. It may be that low IQ,
although a risk factor for schizophrenia
(David et al, 1997),
is not linked with age at onset. However, our cross-sectional study comprised
mostly patients with chronic schizophrenia, and chronicity contributed
strongly to the test scores in the four WAISR scales. The IQ measures
might not have been sensitive enough to show association with age at onset in
the presence of a strong contribution of chronicity. In a large study of
military conscripts, an association was found between poor intellectual
functioning at 18 years of age and onset of schizophrenia about 5 years later
(Gunnell et al,
2002). However, when IQ was controlled for in a study of
adolescent patients with recent onset of schizophrenia, verbal and general
memory impairments were particularly observed
(Kravariti et al,
2003).
Implications of the study
Our results are in agreement with previous studies showing that an early
age at onset of schizophrenia is associated with specific rather than global
cognitive deficits. In our population-based sample of patients with
schizophrenia, this association was found in the verbal learning and memory
functions. Verbal memory deficits known to be highly associated with
functional outcome in schizophrenia
(Green, 1996) should
particularly be taken into account in the neuropsychological evaluation and
efforts at remediation in patients with early-onset disorder. Prospective
research on verbal memory functions during prodromal phases, and on the
predictive value of impairments for disease outcome, is urgently required.
|
|
|---|
Limitations
|
|
|---|
|
|
|---|
Related articles in BJP:
This article has been cited by other articles:
![]() |
M. T. Compton, M. E. Kelley, C. E. Ramsay, M. Pringle, S. M. Goulding, M. L. Esterberg, T. Stewart, and E. F. Walker Association of Pre-Onset Cannabis, Alcohol, and Tobacco Use With Age at Onset of Prodrome and Age at Onset of Psychosis in First-Episode Patients Am J Psychiatry, November 1, 2009; 166(11): 1251 - 1257. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. K. Rajji, Z. Ismail, and B. H. Mulsant Age at onset and cognition in schizophrenia: meta-analysis The British Journal of Psychiatry, October 1, 2009; 195(4): 286 - 293. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. F. O'Donnell Cognitive Impairment in Schizophrenia: A Life Span Perspective American Journal of Alzheimer's Disease and Other Dementias, November 1, 2007; 22(5): 398 - 405. [Abstract] [PDF] |
||||
![]() |
E. J. Davies Developmental aspects of schizophrenia and related disorders: possible implications for treatment strategies Adv. Psychiatr. Treat., September 1, 2007; 13(5): 384 - 391. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. J Hagan and D. N C Jones Predicting Drug Efficacy for Cognitive Deficits in Schizophrenia Schizophr Bull, October 1, 2005; 31(4): 830 - 853. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. JOYCE Origins of cognitive dysfunction in schizophrenia: clues from age at onset The British Journal of Psychiatry, February 1, 2005; 186(2): 93 - 95. [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||